{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:57:46Z","timestamp":1792191466969,"version":"4.4.0"},"reference-count":30,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,8,28]]},"abstract":"<jats:sec>\n                  <jats:title>Background\/objectives<\/jats:title>\n                  <jats:p>Rilonacept (RI), an interleukin (IL)-1\u03b1\/\u03b2 cytokine trap, is a biological treatment to prevent recurrence in recurrent pericarditis (RP). Discontinuation of RI in patients after 18 months with RP has been associated with a higher rate of RP. We aimed to propose a preliminary strategy for stopping Rl in select patients and evaluate their long-term outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study at the pericardial disease centre at Cleveland Clinic, Ohio. Adults included had RP refractory to first-line therapies, receiving Rl for at least 12 months (median duration 24 months) with improvement in symptoms and late gadolinium enhancement on cardiac MRI. The primary outcome was recurrence of RP post abrupt Rl discontinuation versus slow taper (gradual decrease in Rl frequency from weekly, to bimonthly, to monthly and then cessation). We also evaluated the effects of colchicine prophylaxis at the end of Rl therapy, time to recurrence and the overall safety profile of long-term Rl therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 53 patients were included in the study (61.8% female; mean age 54.6\u00b114.17\u2009y), of which 34 (62%) discontinued RI abruptly\/without tapering and 19 (35%) underwent a RI taper after shared decision making with their clinician. A higher percentage of recurrent cases was observed in the abrupt cessation arm (82%) versus the taper arm (37%) (p=0.042). Treatment with colchicine post-completion of Rl therapy was associated with delaying the average time to flare by 60.7 weeks. Most patients (80%) resumed Rl after a recurrence. Long-term Rl therapy was well-tolerated during the follow-up period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Long-term Rl therapy beyond 18\u201324 months leads to sustained disease remission in RP, and therapy withdrawal is associated with a recurrence in two-thirds of patients. A strategy that involves a gradual taper of RI therapy appears to be associated with a relatively lower risk of disease recurrence compared with discontinuation without tapering. Larger-scale, multicentre studies with extended follow-up periods are warranted to elucidate optimal treatment durations and to establish standardised cessation protocols.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2024-325515","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:20:23Z","timestamp":1760980823000},"page":"heartjnl-2024-325515","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-6493","authenticated-orcid":false,"given":"Ushasi","family":"Saraswati","sequence":"first","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5776-7761","authenticated-orcid":false,"given":"Jaideep Singh","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-1313","authenticated-orcid":false,"given":"Larisa G","family":"Tereshchenko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic Research, Quantitative Health Sciences, Cleveland Clinic, Johns Hopkins University School of Medicine, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Heine","sequence":"additional","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alveena Batool","family":"Syed","sequence":"additional","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-9402","authenticated-orcid":false,"given":"Tom Kai Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C","family":"Cremer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Bluhm Cardiovascular Institute, Departments of Medicine and Radiology, Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[{"name":"Robert M. Berne Cardiovascular Research Center and Department of Medicine, Virginia Commonwealth University, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[{"name":"Department of Medicine (DMED), University Hospital Santa Maria Della Misericordia, University of Udine and Cardiothoracic Department, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-8369","authenticated-orcid":false,"given":"Allan L","family":"Klein","sequence":"additional","affiliation":[{"name":"Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institiute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2025102010201544000_heartjnl-2024-325515v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318"},{"key":"2025102010201544000_heartjnl-2024-325515v1.2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11739-021-02639-6","article-title":"Recurrent pericarditis: an update on diagnosis and management","volume":"16","author":"Andreis","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2025102010201544000_heartjnl-2024-325515v1.3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018950","article-title":"US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis","volume":"10","author":"Klein","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025102010201544000_heartjnl-2024-325515v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15826"},{"key":"2025102010201544000_heartjnl-2024-325515v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027892"},{"key":"2025102010201544000_heartjnl-2024-325515v1.6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032516","article-title":"Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept","volume":"13","author":"Imazio","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2025102010201544000_heartjnl-2024-325515v1.7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18865\/ed.31.1.9","article-title":"Should We Implement Geographic or Patient-Reported Social Determinants of Health Measures In Cardiovascular Patients","volume":"31","author":"Kostelanetz","year":"2021","journal-title":"Ethn Dis"},{"key":"2025102010201544000_heartjnl-2024-325515v1.8","first-page":"937","article-title":"Pericardial Diseases","volume":"17","author":"Klein","year":"2024","journal-title":"JACC: Cardiovascular Imaging"},{"key":"2025102010201544000_heartjnl-2024-325515v1.9","unstructured":"Sivalokanathan S , Chokshi N . Pericarditis in athletes: approach to exercise restriction. American College of Cardiology; 2022. Available: https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2022\/09\/06\/11\/53\/Pericarditis-in-Athletes"},{"key":"2025102010201544000_heartjnl-2024-325515v1.10","unstructured":"StataCorp . StataNow MP 18.5. College Station, TX: StataCorp LLC, 2024."},{"key":"2025102010201544000_heartjnl-2024-325515v1.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000677"},{"key":"2025102010201544000_heartjnl-2024-325515v1.12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11886-022-01719-z","article-title":"Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022","volume":"24","author":"Hagerty","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2025102010201544000_heartjnl-2024-325515v1.13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2459\/JCM.0000000000001618","article-title":"Medical therapy of pericarditis: tips and tricks for clinical practice","volume":"25","author":"Imazio","year":"2024","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2025102010201544000_heartjnl-2024-325515v1.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.315937"},{"key":"2025102010201544000_heartjnl-2024-325515v1.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-273417"},{"key":"2025102010201544000_heartjnl-2024-325515v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.04.046"},{"key":"2025102010201544000_heartjnl-2024-325515v1.17","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3280110616"},{"key":"2025102010201544000_heartjnl-2024-325515v1.18","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319879534"},{"key":"2025102010201544000_heartjnl-2024-325515v1.19","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMc2101978","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","author":"Lazaros","year":"2021","journal-title":"N Engl J Med"},{"key":"2025102010201544000_heartjnl-2024-325515v1.20","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002599","article-title":"Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis","volume":"11","author":"Collini","year":"2024","journal-title":"Open Heart"},{"key":"2025102010201544000_heartjnl-2024-325515v1.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.37.23681"},{"key":"2025102010201544000_heartjnl-2024-325515v1.22","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"2025102010201544000_heartjnl-2024-325515v1.23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12969-019-0342-5","article-title":"Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey","volume":"17","author":"Shenoi","year":"2019","journal-title":"Pediatr Rheumatol"},{"key":"2025102010201544000_heartjnl-2024-325515v1.24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jacc.2024.05.072","article-title":"Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis","volume":"84","author":"Yesilyaprak","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025102010201544000_heartjnl-2024-325515v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.23620"},{"key":"2025102010201544000_heartjnl-2024-325515v1.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.23687"},{"key":"2025102010201544000_heartjnl-2024-325515v1.27","doi-asserted-by":"crossref","unstructured":"Hoffman HM , Throne ML , Amar NJ , et al . Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study. Clin Ther 2012;PMID. doi:10.1001\/archinte.165.17.1987","DOI":"10.1016\/j.clinthera.2012.09.009"},{"key":"2025102010201544000_heartjnl-2024-325515v1.28","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.17.1987"},{"key":"2025102010201544000_heartjnl-2024-325515v1.29","first-page":"06503","article-title":"2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"31","author":"Wang","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2025102010201544000_heartjnl-2024-325515v1.30","doi-asserted-by":"crossref","unstructured":"Schulz-Menger J , Collini V , Gr\u00f6schel J , et al . Massimo Imazio, the ESC Scientific Document Group, 2025 ESC Guidelines for the management of myocarditis and pericarditis: Developed by the task force for the management of myocarditis and pericarditis of the European Society of Cardiology (ESC)Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2025. doi:10.1093\/eurheartj\/ehaf192","DOI":"10.1093\/eurheartj\/ehaf192"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2024-325515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:20:26Z","timestamp":1760980826000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2024-325515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":30,"alternative-id":["10.1136\/heartjnl-2024-325515"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2024-325515","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}